Efficacy of thiopropazate dihydrochloride (Dartalan) in treating persisting phenothiazine-induced choreo-athetosis and akathisia.
D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001264:Athetosis / Q000139:chemically induced / Q000188:drug therapy*; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy; D002746:Chlorpromazine / Q000009:adverse effects; D002819:Chorea / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy*; D010640:Phenothiazines / Q000627:therapeutic use*; D013881:Thioridazine / Q000009:adverse effects; D014268:Trifluoperazine / Q000009:adverse effects
D014150:Antipsychotic Agents; D010640:Phenothiazines; D014268:Trifluoperazine; D013881:Thioridazine; D002746:Chlorpromazine